RT Journal Article
SR Electronic
T1 Red blood cell distribution as Potential Predictor of Mortality in Diabetic Foot Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.25.24314391
DO 10.1101/2024.09.25.24314391
A1 Gou, Chunmei
A1 Huang, Siyi
A1 Huang, Li
A1 Wang, Tinggang
A1 Huang, Guangtao
YR 2024
UL http://medrxiv.org/content/early/2024/09/26/2024.09.25.24314391.abstract
AB Background Red blood cell distribution width (RDW) reflects the heterogeneity of red blood cell volume, which reflects the variable width of red blood cell (RBC). RDW has been proved as predictor of mortality among several diseases. The purpose of this study is to analyze the relationship between RDW and mortality of diabetic foot patients.Methods We first collect clinic data from the public database MIMIC-III. Kruskal Wallis rank sum test was used to analyze the association between RDW and DF mortality, and to evaluate the relationship between them. Univariate and multivariate logistic regression analysis was used for determining the risk factors and prognosis of DF patients.Results A total of 283 patients were included in this study, with an average age of 64.0 [54.0,70.5] years, including 193 males and 90 females. We divided RDW into three groups (high, moderate and low) according to RDW tertiles and then compared the mortality of the three groups. The high RDW group (RDW > 16.8%) had significant higher mortality (P = 0.031). In multivariate logistic regression analysis, RDW, SOFA score and APS are risk factors for death in diabetic foot. After adjusting for confounding factors in model II, RDW remains a particularly strong predictor of mortality.Conclusions A total of 283 patients were included in this study, with an average age of 64.0 [54.0,70.5] years, including 1We confirm that RDW is an independent predictor of mortality in DF patients,and the higher the RDW, the higher the mortality of DF patients.Competing Interest StatementThe authors declare that they have no conflicts of interest.Clinical TrialNFunding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The clinical data used to support this study are available from Monitoring in Intensive Care Database III (MIMIC-III), getting these data it requires a permission from the MIMIC database.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe clinical data used to support this study are available from Monitoring in Intensive Care Database III (MIMIC-III), which is publicly available and contains deidentified data from ICU patients. To obtain permission to access the database, researchers must complete the National Institutes of Health’s web-based course called Protecting Human Research Participants (certification number 29493483). The data used in our research adheres to the terms of this agreement, ensuring patient privacy and confidentiality. Researchers can obtain the MIMIC-III data set by following the specified access procedure on PhysioNet.